The prognostic value of stem cell markers in triple-negative breast cancer
In this study, we attempted to match tumor outcomes with the expression of the following stem cell markers: ALDH1, AnnexinA1, CD44, CD117, CD166, Nanog and oct-4. Tissue microarray blocks from triple-negative breast cancers were immunostained for the listed markers, and their expression by the majority of tumor cells (diffuse positivity) was correlated with prognosis. Of the 106 tumors investigated, diffuse positivity was seen in 7 (ALDH1), 33 (AnnexinA1), 53 (CD44), 44 (CD117 membranous only), 49 (CD117), 72 (CD166), 19 (Nanog), and 11 (oct-4) cases. With a median follow-up of 83 months, ALDH1 and CD117 expression was ass...
Source: Pathology Oncology Research - January 8, 2024 Category: Pathology Authors: Szintia Alm ási Ágnes Nagy Tibor Kren ács Tam ás Lantos Tam ás Zombori G ábor Cserni Source Type: research
Spectrum of BCR-ABL mutations in Azerbaijanian imatinib-resistant patients with chronic myeloid leukemia
Conclusion: T315I was the most commonly identified BCR-ABL1 mutation in TKI-resistant CML patients of Azerbaijani origin, being associated with disease progression and poor OS.PMID:38188610 | PMC:PMC10766836 | DOI:10.3389/pore.2023.1611518 (Source: Pathology Oncology Research)
Source: Pathology Oncology Research - January 8, 2024 Category: Pathology Authors: Aypara Hasanova Chingiz Asadov Nigar Karimova Aytan Shirinova Gunay Aliyeva Zohra Alimirzoyeva Source Type: research
Pancreatic SABR using peritumoral fiducials, triggered imaging and breath-hold
Conclusion: Linear accelerator based pancreatic SABR with the combination of CBCT and triggered imaging + beam hold is feasible. Peritumoral fiducials improve utility while breath-hold CBCT provides the best image quality at a reasonable treatment time with offline adaptation possibilities. In well-selected cases, it can be an effective alternative in clinics where CBCT/MRI-guided online adaptive workflow is not available.PMID:38188611 | PMC:PMC10767757 | DOI:10.3389/pore.2023.1611456 (Source: Pathology Oncology Research)
Source: Pathology Oncology Research - January 8, 2024 Category: Pathology Authors: Katalin Kisivan Andrea Farkas Peter Kovacs Csaba Glavak Gabor Lukacs Karoly Mahr Zsolt Szabo Melinda Petone Csima Akos Gulyban Zoltan Toth Zsolt Kaposztas Ferenc Lakosi Source Type: research
Urachus adenocarcinoma mistaken for umbilical incision implant cancer after laparoscopic cholecystectomy: a case report
Pathol Oncol Res. 2023 Dec 22;29:1611334. doi: 10.3389/pore.2023.1611334. eCollection 2023.ABSTRACTUmbilical incision implant cancer after LC is rare. Elective cholecystectomy was planned for a 49 years-old female patient with symptomatic gallstones. The patient underwent transumbilical single-port LC after admission to our hospital. Gallbladder specimens were obtained directly through the umbilical puncture hole, and histopathology suggested chronic cholecystitis. Three months after surgery, the patient experienced painful induration in the umbilicus. We initially considered incision scar hyperplasia complicated with pain...
Source: Pathology Oncology Research - January 8, 2024 Category: Pathology Authors: Yanxing Mai Lei Feng Zhenxi Liu Yu Nie Zesheng Jiang Jiasheng Qin Source Type: research
The prognostic value of stem cell markers in triple-negative breast cancer
In this study, we attempted to match tumor outcomes with the expression of the following stem cell markers: ALDH1, AnnexinA1, CD44, CD117, CD166, Nanog and oct-4. Tissue microarray blocks from triple-negative breast cancers were immunostained for the listed markers, and their expression by the majority of tumor cells (diffuse positivity) was correlated with prognosis. Of the 106 tumors investigated, diffuse positivity was seen in 7 (ALDH1), 33 (AnnexinA1), 53 (CD44), 44 (CD117 membranous only), 49 (CD117), 72 (CD166), 19 (Nanog), and 11 (oct-4) cases. With a median follow-up of 83 months, ALDH1 and CD117 expression was ass...
Source: Pathology Oncology Research - January 8, 2024 Category: Pathology Authors: Szintia Alm ási Ágnes Nagy Tibor Kren ács Tam ás Lantos Tam ás Zombori G ábor Cserni Source Type: research
Retraction: Frequencies of < em > Porphyromonas gingivalis < /em > detection in oral-digestive tract tumors
Pathol Oncol Res. 2023 Dec 19;29:1611616. doi: 10.3389/pore.2023.1611616. eCollection 2023.ABSTRACT[This retracts the article DOI: 10.3389/pore.2021.628942.].PMID:38170116 | PMC:PMC10759536 | DOI:10.3389/pore.2023.1611616 (Source: Pathology Oncology Research)
Source: Pathology Oncology Research - January 3, 2024 Category: Pathology Authors: Pathology and Oncology Research Editorial Office Source Type: research
Retraction: Frequencies of < em > Porphyromonas gingivalis < /em > detection in oral-digestive tract tumors
Pathol Oncol Res. 2023 Dec 19;29:1611616. doi: 10.3389/pore.2023.1611616. eCollection 2023.ABSTRACT[This retracts the article DOI: 10.3389/pore.2021.628942.].PMID:38170116 | PMC:PMC10759536 | DOI:10.3389/pore.2023.1611616 (Source: Pathology Oncology Research)
Source: Pathology Oncology Research - January 3, 2024 Category: Pathology Authors: Pathology and Oncology Research Editorial Office Source Type: research
Retraction: Frequencies of < em > Porphyromonas gingivalis < /em > detection in oral-digestive tract tumors
Pathol Oncol Res. 2023 Dec 19;29:1611616. doi: 10.3389/pore.2023.1611616. eCollection 2023.ABSTRACT[This retracts the article DOI: 10.3389/pore.2021.628942.].PMID:38170116 | PMC:PMC10759536 | DOI:10.3389/pore.2023.1611616 (Source: Pathology Oncology Research)
Source: Pathology Oncology Research - January 3, 2024 Category: Pathology Authors: Pathology and Oncology Research Editorial Office Source Type: research
Retraction: Associations of porphyromonas gingivalis infection and low beclin1 expression with clinicopathological parameters and survival of esophageal squamous cell carcinoma patients
Pathol Oncol Res. 2023 Dec 14;29:1611617. doi: 10.3389/pore.2023.1611617. eCollection 2023.ABSTRACT[This retracts the article DOI: 10.3389/pore.2021.1609976.].PMID:38155817 | PMC:PMC10754261 | DOI:10.3389/pore.2023.1611617 (Source: Pathology Oncology Research)
Source: Pathology Oncology Research - December 29, 2023 Category: Pathology Authors: Pathology and Oncology Research Editorial Office Source Type: research
Retraction: Associations of porphyromonas gingivalis infection and low beclin1 expression with clinicopathological parameters and survival of esophageal squamous cell carcinoma patients
Pathol Oncol Res. 2023 Dec 14;29:1611617. doi: 10.3389/pore.2023.1611617. eCollection 2023.ABSTRACT[This retracts the article DOI: 10.3389/pore.2021.1609976.].PMID:38155817 | PMC:PMC10754261 | DOI:10.3389/pore.2023.1611617 (Source: Pathology Oncology Research)
Source: Pathology Oncology Research - December 29, 2023 Category: Pathology Authors: Pathology and Oncology Research Editorial Office Source Type: research
Retraction: Associations of porphyromonas gingivalis infection and low beclin1 expression with clinicopathological parameters and survival of esophageal squamous cell carcinoma patients
Pathol Oncol Res. 2023 Dec 14;29:1611617. doi: 10.3389/pore.2023.1611617. eCollection 2023.ABSTRACT[This retracts the article DOI: 10.3389/pore.2021.1609976.].PMID:38155817 | PMC:PMC10754261 | DOI:10.3389/pore.2023.1611617 (Source: Pathology Oncology Research)
Source: Pathology Oncology Research - December 29, 2023 Category: Pathology Authors: Pathology and Oncology Research Editorial Office Source Type: research
Retraction: Associations of porphyromonas gingivalis infection and low beclin1 expression with clinicopathological parameters and survival of esophageal squamous cell carcinoma patients
Pathol Oncol Res. 2023 Dec 14;29:1611617. doi: 10.3389/pore.2023.1611617. eCollection 2023.ABSTRACT[This retracts the article DOI: 10.3389/pore.2021.1609976.].PMID:38155817 | PMC:PMC10754261 | DOI:10.3389/pore.2023.1611617 (Source: Pathology Oncology Research)
Source: Pathology Oncology Research - December 29, 2023 Category: Pathology Authors: Pathology and Oncology Research Editorial Office Source Type: research
Retraction: Associations of porphyromonas gingivalis infection and low beclin1 expression with clinicopathological parameters and survival of esophageal squamous cell carcinoma patients
Pathol Oncol Res. 2023 Dec 14;29:1611617. doi: 10.3389/pore.2023.1611617. eCollection 2023.ABSTRACT[This retracts the article DOI: 10.3389/pore.2021.1609976.].PMID:38155817 | PMC:PMC10754261 | DOI:10.3389/pore.2023.1611617 (Source: Pathology Oncology Research)
Source: Pathology Oncology Research - December 29, 2023 Category: Pathology Authors: Pathology and Oncology Research Editorial Office Source Type: research
Retraction: Associations of porphyromonas gingivalis infection and low beclin1 expression with clinicopathological parameters and survival of esophageal squamous cell carcinoma patients
Pathol Oncol Res. 2023 Dec 14;29:1611617. doi: 10.3389/pore.2023.1611617. eCollection 2023.ABSTRACT[This retracts the article DOI: 10.3389/pore.2021.1609976.].PMID:38155817 | PMC:PMC10754261 | DOI:10.3389/pore.2023.1611617 (Source: Pathology Oncology Research)
Source: Pathology Oncology Research - December 29, 2023 Category: Pathology Authors: Pathology and Oncology Research Editorial Office Source Type: research
Comparative analysis of EZH2, p16 and p53 expression in uterine carcinosarcomas
Conclusion: In conclusion, EZH2, p16 and p53 seem to play a universal role in the pathogenesis of UCS; however, a distinctive pattern of p53 expression appears to exist between the serous and endometrioid carcinoma components and also between the homologous and heterologous sarcoma components.PMID:38146588 | PMC:PMC10749357 | DOI:10.3389/pore.2023.1611547 (Source: Pathology Oncology Research)
Source: Pathology Oncology Research - December 26, 2023 Category: Pathology Authors: Evelin Makk No émi Bohonyi Ang éla Oszter Kl ára Éles Tam ás Tornóczky Arnold T óth Endre K álmán Krisztina Kov ács Source Type: research
